REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/07/2026
Back to search
Official data from USPTO
PHARMING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/08/2026
Trademark type
Combined
Nice classes
5
Filing date
07/05/2016
Registration date
03/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2023
Last transaction
03/08/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
16
Owner location
Leiden, NL
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
TMO LAW OFFICE 114
Mark description
The mark consists of a dark blue square with a light blue center to the left of the word "PHARMING" which appears in gray.
Holders and representatives
Holders
Pharming Intellectual Property B.V.
Pharming Intellectual Property B.V.
Representatives
Mark D. Passler Blank Rome
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricgenetic disorders and immune system related diseases and disorders
Publications
History of USPTO decisions and trademark events.
34 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/04/2026
NOSU
NOTICE OF SUIT
01/16/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/28/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/27/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/27/2023
PUMI
PROOF OF USE INTERIM ACTION ISSUED
05/23/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/18/2023
PUM1
OFFICE ACTION ISSUED POU1
03/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/20/2023
NOSU
NOTICE OF SUIT
12/09/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2017
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
02/02/2017
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/31/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/31/2017
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/24/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/06/2016
PUBO
PUBLISHED FOR OPPOSITION
12/06/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/03/2016
ALIE
ASSIGNED TO LIE
11/03/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
10/18/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/18/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
10/18/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/18/2016
DOCK
ASSIGNED TO EXAMINER
10/13/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2016
NWAP
NEW APPLICATION ENTERED
07/08/2016
Continuous trademark protection
Get notified about every new filing that threatens PHARMING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.